Evidence map›Paper›PMID 37764241›Full record

ArticleMolecules (Basel, Switzerland)2023

Structural Expansion of Catalytic RNA Nanostructures through Oligomerization of a Cyclic Trimer of Engineered Ribozymes.

Mst Ayesha Siddika, Hiroki Oi, Kumi Hidaka, Hiroshi Sugiyama, Masayuki Endo, Shigeyoshi Matsumura, Yoshiya Ikawa

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mst Ayesha SiddikaGraduate School of Innovative Life Science, University of Toyama, Toyama 930-8555, Toyama, Japan.ORCID 0000-0003-0940-1559
Hiroki OiDepartment of Chemistry, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Toyama, Japan.
Kumi HidakaDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto 606-8501, Kyoto, Japan.
Hiroshi SugiyamaInstitute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8501, Kyoto, Japan.ORCID 0000-0001-8923-5946
Masayuki EndoInstitute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8501, Kyoto, Japan.
Shigeyoshi MatsumuraGraduate School of Innovative Life Science, University of Toyama, Toyama 930-8555, Toyama, Japan.
Yoshiya IkawaGraduate School of Innovative Life Science, University of Toyama, Toyama 930-8555, Toyama, Japan.ORCID 0000-0002-6814-0443
University of Toyama · JPKyoto University · JP

Funding

MEXT KAKENHI JP23K04939University of Toyama Discretionary Funds of the President FY2022
6 · The paper itself

Abstract

The multimolecular assembly of three-dimensionally structured proteins forms their quaternary structures, some of which have high geometric symmetry. The size and complexity of protein quaternary structures often increase in a hierarchical manner, with simpler, smaller structures serving as units for larger quaternary structures. In this study, we exploited oligomerization of a ribozyme cyclic trimer to achieve larger ribozyme-based RNA assembly. By installing kissing loop (KL) interacting units to one-, two-, or three-unit RNA molecules in the ribozyme trimer, we constructed dimers, open-chain oligomers, and branched oligomers of ribozyme trimer units. One type of open-chain oligomer preferentially formed a closed tetramer containing 12 component RNAs to provide 12 ribozyme units. We also observed large assembly of ribozyme trimers, which reached 1000 nm in size.

Indexed as

NanostructuresRNA, CatalyticModels, MolecularNucleic Acid ConformationRNA, Catalyticgroup IribozymeRNA motifRNA nanostructureTetrahymena

Identifiers

PMID37764241
PMCPMC10535472
OpenAlexW4386483860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.